the disaster prompted many countries to introduce tougher rules for the testing and licensing of drugs. in the united states, the new regulations strengthened the fda, among other ways, by requiring applicants to prove efficacy and to disclose all side effects encountered in testing. the fda subsequently initiated the drug efficacy study implementation to reclassify drugs already on the market.